Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC Study

In patients with chronic kidney disease (CKD), clinical interest often centers on determining treatments and exposures that are causally related to renal progression. Analyses of longitudinal clinical data in this population are often complicated by clinical competing events, such as end-stage renal disease (ESRD) and death, and time-dependent confounding, where patient factors that are predictive of later exposures and outcomes are affected by past exposures. We developed multistate marginal structural models (MS-MSMs) to assess the effect of time-varying systolic blood pressure on disease progression in subjects with CKD. The multistate nature of the model allows us to jointly model disease progression characterized by changes in the estimated glomerular filtration rate (eGFR), the onset of ESRD, and death, and thereby avoid unnatural assumptions of death and ESRD as noninformative censoring events for subsequent changes in eGFR. We model the causal effect of systolic blood pressure on the probability of transitioning into 1 of 6 disease states given the current state. We use inverse probability weights with stabilization to account for potential time-varying confounders, including past eGFR, total protein, serum creatinine, and hemoglobin. We apply the model to data from the Chronic Renal Insufficiency Cohort Study, a multisite observational study of patients with CKD.

[1]  Jackson T. Wright,et al.  Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. , 2015, Annals of internal medicine.

[2]  Liang Li,et al.  Longitudinal progression trajectory of GFR among patients with CKD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Peter J Diggle,et al.  Joint modelling of repeated measurement and time-to-event data: an introductory tutorial. , 2015, International journal of epidemiology.

[4]  Stephen R Cole,et al.  The consistency statement in causal inference: a definition or an assumption? , 2009, Epidemiology.

[5]  David A Stephens,et al.  A marginal structural model for multiple‐outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co‐infection Cohort , 2014, Statistics in medicine.

[6]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[7]  D. Rubin Estimating causal effects of treatments in randomized and nonrandomized studies. , 1974 .

[8]  D. Rubin Statistics and Causal Inference: Comment: Which Ifs Have Causal Answers , 1986 .

[9]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[10]  Sheena McConnell,et al.  The Truncation-by-Death Problem , 2008, Evaluation review.

[11]  D. Rubin Causal Inference Through Potential Outcomes and Principal Stratification: Application to Studies with “Censoring” Due to Death , 2006, math/0612783.

[12]  Adele H. Marshall,et al.  Advances in Joint Modelling: A Review of Recent Developments with Application to the Survival of End Stage Renal Disease Patients , 2013 .

[13]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[14]  Michael Rosenblum,et al.  Marginal Structural Models , 2011 .

[15]  J. Robins,et al.  Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments , 2001 .

[16]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[17]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[18]  Odd O. Aalen,et al.  Causal inference in multi-state models–sickness absence and work for 1145 participants after work rehabilitation , 2015, BMC Public Health.

[19]  W G Havercroft,et al.  Simulating from marginal structural models with time‐dependent confounding , 2012, Statistics in medicine.

[20]  S. Greenland,et al.  Epidemiologic measures and policy formulation: lessons from potential outcomes , 2005, Emerging themes in epidemiology.